SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-095907
Filing Date
2023-12-15
Accepted
2023-12-15 08:30:09
Documents
13
Period of Report
2023-12-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190096-8k_180life.htm   iXBRL 8-K 32000
  Complete submission text file 0001213900-23-095907.txt   251332

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20231214.xsd EX-101.SCH 3787
3 XBRL DEFINITION FILE atnf-20231214_def.xml EX-101.DEF 26629
4 XBRL LABEL FILE atnf-20231214_lab.xml EX-101.LAB 36680
5 XBRL PRESENTATION FILE atnf-20231214_pre.xml EX-101.PRE 25253
7 EXTRACTED XBRL INSTANCE DOCUMENT ea190096-8k_180life_htm.xml XML 5302
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 231488848
SIC: 2834 Pharmaceutical Preparations